The Valley Desk

Clinical trial reportThe New England journal of medicinePublished

Teclistamab plus Daratumumab in Relapsed or Refractory Multiple Myeloma

15 of 45 authors shown in byline order.

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

Publication record

Type
Clinical trial report
Venue
The New England journal of medicine
Published
Subject terms
Humans; Multiple Myeloma; Neoplasm Recurrence, Local; Thalidomide; Dexamethasone; Antineoplastic Combined Chemotherapy Protocols; Antibodies, Bispecific; Antibodies, Monoclonal; Injections, Subcutaneous; Drug Resistance, Neoplasm; Time Factors; Adult
PubMed ID
41363801
PubMed Central ID
PMC13218738
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal